Pathways to Cancer
March 11 - 14
Invited Speakers: Keynote Address:
Ed Scolnick, Merck Research Laboratories
Invited Speakers:
David Beach, Cold Spring Harbor Laboratory
Melanie Cobb, University Texas Southwestern Medical Center
Philip Cohen, Dundee University
Sara Courtneidge, Sugen, Inc.
Judah Folkman, Children's Hospital
Errol Friedberg, University of Texas Southwestern Medical School
Doug Hanahan, University of California, San Francisco
David Housman, Massachusettts Institute of Technology
Michael Ittmann, Houston Veterans Administration Medical Center
Rakesh Jain, Massachusetts General Hospital
Scott Kern, The Johns Hopkins Medical Institutions
Elliott Kieff, Harvard University
Marc Kirschner, Harvard Medical School
Stanley Korsmeyer, Washington University School of Medicine
Joseph Nevins, Duke University Medical Center
Roel Nusse, Stanford University
Tony Pawson, Samuel Lunenfeld Research Institute/Mt. Sinai Hospital
Mark Peifer, University of North Carolina
Bruce Ponder, CRC/ Addenbrookes Hospital, UK
Carol Prives, Columbia University
Gerald M. Rubin, HHMI/ University of California, Berkeley
Erkki Ruoslahti, The Burnham Institute
Charles Sherr, HHMI/ St. Jude
Children's Research Hospital
Harold Varmus, National Institutes of Health
Robert A. Weinberg, Whitehead Institute for Biomedical Research
Michael Wigler, Cold Spring Harbor Laboratory
Program:
You are cordially invited to participate in a special winter conference on Pathways to Cancer which will be held at Cold Spring Harbor Laboratory, in celebration of James D. Watson’s 50 year association with the Laboratory. The meeting will begin on the evening of Wednesday March 11th, and will conclude with lunch on Saturday, March 14th, 1998. We are planning presentations in three main themes, based on three complementary ways of thinking about pathways to cancer:
* mechanistic changes that lead to cancer - mutations, cell
cycle, tumor development
* reviews of examples of specific pathways involved in cancer - ras-raf,
wnt, and p16-Rb/E2f
* pathways to specific cancers and how that molecular knowledge is being or
might be used clinically - breast, colon, prostate, melanoma
We encourage you to register and submit poster abstracts for the meeting electronically at our web site (see url below). Poster presentations will be limited to a maximum of sixty selected posters based both on scientific merit and fair representation of laboratories. If you are unable to register electronically, registration materials are available from the address below. Please bring this notice to the attention of any of your colleagues who may be interested. We hope to see you at Cold Spring Harbor.
Registration :
You may register online here
Deadline for Abstracts: NA
Email for Requests and Registration: meetings@cshl.org